Correction to: High dose rate intra-cavitary brachytherapy with cobalt 60 source for locally advanced cervical cancer: the Zimbabwean experience

Chibonda, Shirley; Ndlovu, Ntokozo; Tsikai, Nomsa; Munangaidzwa, Lameck; Ndarukwa, Sandra; Nyamhunga, Albert; Mazhindu, Tinashe

doi:10.1186/s13027-021-00348-5

Cited by 1 publication

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Currently, in numerous nations, including Nigeria, Ghana, Zimbabwe, and Botswana [15][16][17], HDR afterloaders are used (Table 2). Although there is no evidence to suggest that LDL and HDL techniques have any impact on clinical outcomes [18], HDR has the advantage of reducing staff's and patient's radiation exposure and can treat more patients each week than LDR [19]. One advantage of LDR is that the radioisotope generally utilized is cesium-137, which has a 30-year halflife.…”

Section: Current Availability Of Brachytherapy Infrastructure and Cap...mentioning

confidence: 99%

“…On the other hand, the HDR sources (iridium-192 has a half-life of 74 days, and cobalt-60 has a half-life of 5.3 years) have a shorter half-life, and hence require regular replacement. This presents significant logistical and regulatory issues for countries, which use these radioisotopes [15][16][17][18][19][20][21][22][23][24][25].…”

Section: Current Availability Of Brachytherapy Infrastructure and Cap...mentioning

confidence: 99%

See 1 more Smart Citation

Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination

Tumba¹,

Theyra-Enias²

2022

jcb

View full text Add to dashboard Cite

Purpose Sub-Saharan Africa has the highest burden of cervical cancer in the world. The African continent has only 5% of the world’s cancer care resources, and brachytherapy is an important part of treatment of cervical cancer. This study explored the availability of brachytherapy units in Africa. Material and methods We used publicly available data on cervical cancer and brachytherapy from GLOBOCAN 2018 database hosted by IARC and Directory of Radiotherapy Centers (DIRAC) presented by IAEA, respectively. Number of brachytherapy units per 1,000 new cases was calculated as an index for comparison between groups. Results There are 101 brachytherapy units in 20 African countries, accounting for 3% (101/3,375) of total global units. Sub-Saharan Africa accounts for half of these units (50/101). Egypt has the highest number of units per 1,000 new cases (23.7 units/1,000 new cases), while Nigeria has the least with 0.13 units per 1,000 new cases. No country in central African region has a brachytherapy unit. More than 70% of brachytherapy units are located in five countries (Algeria, Kenya, Egypt, Morocco, and South Africa). Conclusions In order to treat 90 percent of invasive cervical cancer on the continent, Africa needs a continental political action plan and massive investment in brachytherapy equipment over the next ten years.

show abstract

Section: Current Availability Of Brachytherapy Infrastructure and Cap...mentioning

confidence: 99%

Section: Current Availability Of Brachytherapy Infrastructure and Cap...mentioning

confidence: 99%

Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination

Tumba¹,

Theyra-Enias²

2022

jcb

View full text Add to dashboard Cite

show abstract

Correction to: High dose rate intra-cavitary brachytherapy with cobalt 60 source for locally advanced cervical cancer: the Zimbabwean experience

Abstract: An amendment to this paper has been published and can be accessed via the original article.

Cited by 1 publication

References 1 publication

Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination

Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination

Contact Info

Product

Resources

About